Moderna edges Pfizer in study of 5 COVID vaccines
The Moderna and Russian Sputnik V COVID-19 vaccines both edged the version from Pfizer in effectiveness in a large-scale study of five different immunization shots conducted by Hungarian researchers.
Moderna’s vaccine was 88.7% effective in protecting against coronavirus infection and 93.6% effective against COVID-related mortality, compared with 85.7% and 95.4%, respectively, for Sputnik, according to the paper published Wednesday on the website of the Clinical Microbiology and Infection medical journal. Pfizer came in third with 83.3% and 90.6%, respectively.
The research reviewed the effectiveness of five vaccines in people at least seven days after they received their second dose. Data from more than 3.7 million vaccinated people aged 16 and over were reviewed from January to June of this year.
“The wide range of vaccines available in Hungary allows for …
More on: www.seattletimes.com